L164-0651 Screening compound: 1-[4-(4-cyclohexylbenzenesulfonamido)phenyl]-N-(cyclohexylmethyl)cyclopropane-1-carboxamide

L164-0651 Screening compound: 1-[4-(4-cyclohexylbenzenesulfonamido)phenyl]-N-(cyclohexylmethyl)cyclopropane-1-carboxamide
L164-0651 Screening compound: 1-[4-(4-cyclohexylbenzenesulfonamido)phenyl]-N-(cyclohexylmethyl)cyclopropane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L164-0651
1-[4-(4-cyclohexylbenzenesulfonamido)phenyl]-N-(cyclohexylmethyl)cyclopropane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L164-0651

Molecular Formula

C29H38N2O3S (C29 H38 N2 O3 S)

Compound Name

1-[4-(4-cyclohexylbenzenesulfonamido)phenyl]-N-(cyclohexylmethyl)cyclopropane-1-carboxamide

IUPAC name

1-[4-(4-cyclohexylbenzenesulfonamido)phenyl]-N-(cyclohexylmethyl)cyclopropane-1-carboxamide

SMILES

O=C(C1(CC1)c(cc1)ccc1NS(c1ccc(C2CCCCC2)cc1)(=O)=O)NCC1CCCCC1

InChI

InChI=1S/C29H38N2O3S/c32-28(30-21-22-7-3-1-4-8-22)29(19-20-29)25-13-15-26(16-14-25)31-35(33,34)27-17-11-24(12-18-27)23-9-5-2-6-10-23/h11-18,22-23,31H,1-10,19-21H2,(H,30,32)

InChI Key

BATSGUUQXNWJNN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15120281

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

494.7

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.918

Distribution Coefficient, logD

6.906

Water Solubility, LogSw

-6.13

Polar Surface Area

65.666

Acid Dissociation Constant (pKa)

8.95

Base Dissociation Constant (pKb)

1.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

55.20

L164-0651 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L164-0651 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L164-0651?
Check Price and Availability of L164-0651, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L164-0651 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L164-0651
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L164-0651
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L164-0651 available by request